Kidney cancer: From tumor biology to innovative therapeutics
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Renal cell carcinoma (RCC) is a deadly kidney cancer often diagnosed late. Recent research identifies key mechanisms and novel therapies targeting oncogenic pathways and immune responses to improve patient survival.
Area Of Science
- Oncology
- Molecular Biology
- Genetics
Background
- Renal cell carcinoma (RCC) is a prevalent and lethal kidney cancer, often diagnosed at advanced stages due to asymptomatic presentation.
- Prognosis for RCC significantly depends on cancer stage, with localized disease having a better outlook than metastatic RCC.
- Risk factors include obesity, smoking, genetic mutations, family history, and inherited disorders like Tuberous Sclerosis and von Hippel-Lindau syndrome.
Purpose Of The Study
- To review recent discoveries in the pathogenic mechanisms of RCC.
- To highlight novel therapeutic strategies for RCC that target oncogenic pathways and immune defenses.
Main Methods
- Utilizing genetic screening, deep sequencing, quantitative proteomics, and immunostaining on various biological samples.
- Employing in vitro and animal models for functional analysis of RCC cell biology.
- Integrating gene-targeting strategies with functional studies to understand RCC pathogenesis.
Main Results
- Identification of novel biomarkers, predisposing factors, and therapeutic targets for RCC.
- Characterization of pathogenic mechanisms underlying RCC development and progression.
- Development of targeted therapeutics that restore cancer cell signaling and immune checkpoints.
Conclusions
- Advances in molecular analysis have elucidated key RCC mechanisms.
- Novel targeted therapies show promise in improving survival rates for RCC patients.
- Restoring immune defenses and interrupting oncogenic pathways are crucial therapeutic goals.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...